Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
NCT04036188Phase 1Recruiting
- Sponsor
- Wright State University
- Start
- Oct 2019
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in plaque psoriasis comparing Triamcinolone Cream + Vitamin D3 with Triamcinolone Cream + Placebo (2 arms). Primary endpoints: Psoriasis Area and Severity Index at 28 weeks, Investigator Grade Assessment at 28 weeks and 1 more. Started Oct 2019; status: recruiting.
02
Drugs
vitamin d
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04036188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04036188.